Connect with others who understand.

  •   Learn from expert-reviewed resources
  •   Real advice from people who’ve been there
  •   People who understand what you’re going through
Sign Up Log In
All Resources Treatments A-Z Personal Assistant Help Center Crisis
Powered By
Real members of MyLeukemiaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.

Is anyone familiar with triplet therapy for unmutated CLL?

A MyLeukemiaTeam Member asked a question in Chronic Leukemia group 💭
Thousand Oaks, CA

Hi there, first time posting, but I have been reading so many of your stories, words of encouragement and experiences for awhile now. I was diagnosed May 2025 with a mutated and unmutated clone and negative for Richter's transformation. I have been on watch and wait, but have had all sorts of weird stuff (that never happened before diagnosis!) going on since July. First it was the crazy bug bite reaction which calmed down after about 6 months. In August, I developed enlarged tonsils and 3 weeks… read more

April 15
 · 
Reactions
MyLeukemiaTeam

Are you familiar with triplet therapy combining obinutuzumab, venetoclax, and a BTK inhibitor like zanubrutinib for unmutated CLL?

Triplet therapy for CLL is an emerging approach that combines three different types of medications to target leukemia cells more aggressively. Your doctor mentioned combining obinutuzumab (a Show Full Answer

Are you familiar with triplet therapy combining obinutuzumab, venetoclax, and a BTK inhibitor like zanubrutinib for unmutated CLL?

Triplet therapy for CLL is an emerging approach that combines three different types of medications to target leukemia cells more aggressively. Your doctor mentioned combining obinutuzumab (a monoclonal antibody), venetoclax (a targeted therapy), and zanubrutinib or similar (a BTK inhibitor).

While the search results don't specifically discuss this exact triplet combination, they do mention that multiple medications are often given together to treat CLL, and that targeted therapy drugs like venetoclax, obinutuzumab, and BTK inhibitors (such as ibrutinib and acalabrutinib) can be used alone or in different combinations.

Treatment decisions for unmutated CLL often involve more aggressive approaches since unmutated cases can be higher-risk. Your doctor's plan to consult with a CLL specialist is excellent, as they'll have the most current knowledge about newer combination therapies and clinical trials.

Given your situation with the concerning Ki-67 proliferation rate and fluctuating platelets, it makes sense your doctor is exploring options. The fact that your platelets have improved is encouraging, but close monitoring with your upcoming CT scan and bloodwork will help guide the next steps.

It's worth asking your doctor about clinical trials for triplet therapy combinations, as these studies often provide access to cutting-edge treatment approaches that aren't yet widely available.

April 15

Related Questions

View All
Oral Therapy vs. Traditional Chemotherapy for CLL/SLL
Watch and Wait With CLL/SLL: When Should You Start Treatment?
8 Ways To Live Better With CLL